Abstract:BackgroundPigs have many features that make them attractive as biomedical models for various diseases, including cancer. P53 is an important tumor suppressor gene that exerts a central role in protecting cells from oncogenic transformation and is mutated in a large number of human cancers. P53 mutations occur in almost every type of tumor and in over 50% of all tumors. In a recent publication, pigs with a mutated P53 gene were generated that resulted in lymphoma and renal and osteogenic tumors. However, approximately 80% of human tumors have dysfunctional P53. A P53-deficient pig model is still required to elucidate.MethodsTranscription activator-like effector nucleases (TALENs) were designed to target porcine P53 exon 4. The targeting activity was evaluated using a luciferase SSA recombination assay. P53 biallelic knockout (KO) cell lines were established from single-cell colonies of fetal fibroblasts derived from Diannan miniature pigs followed by electroporation with TALENs plasmids. One cell line was selected as the donor cell line for somatic cell nuclear transfer (SCNT) for the generation of P53 KO pigs. P53 KO stillborn fetuses and living piglets were obtained. Gene typing of the collected cloned individuals was performed by T7EI assay and sequencing. Fibroblast cells from Diannan miniature piglets with a P53 biallelic knockout or wild type were analyzed for the P53 response to doxorubicin treatment by confocal microscopy and western blotting.ResultsThe luciferase SSA recombination assay revealed that the targeting activities of the designed TALENs were 55.35-fold higher than those of the control. Eight cell lines (8/19) were mutated for P53, and five of them were biallelic knockouts. One of the biallelic knockout cell lines was selected as nuclear donor cells for SCNT. The cloned embryos were transferred into five recipient gilts, three of them becoming pregnant. Five live fetuses were obtained from one surrogate by caesarean section after 38 days of gestation for genotyping. Finally, six live piglets and one stillborn piglet were collected from two recipients by caesarean section. Sequencing analyses of the target site confirmed the P53 biallelic knockout in all fetuses and piglets, consistent with the genotype of the donor cells. The qPCR analysis showed that the expression of the P53 mRNA had significant reduction in various tissues of the knockout piglets. Furthermore, confocal microscopy and western blotting analyses demonstrated that the fibroblast cells of Diannan miniature piglets with a P53 biallelic knockout were defective in mediating DNA damage when incubated with doxorubicin.ConclusionTALENs combined with SCNT was successfully used to generate P53 KO Diannan miniature pigs. Although these genetically engineered Diannan miniature pigs had no tumorigenic signs, the P53 gene was dysfunctional. We believe that these pigs will provide powerful new resources for preclinical oncology and basic cancer research.

Production of p53 gene knockout rats by homologous recombination in embryonic stem cells

Generating gene knockout rats by homologous recombination in embryonic stem cells

An optimized proliferation system of embryonic stem cells for generating the rat model with large fragment modification

Retake the center stage--new development of rat genetics.

Generation of site-specific mutations in the rat genome via CRISPR/Cas9.

Genetic Modification and Screening in Rat Using Haploid Embryonic Stem Cells.

Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts

CRISPR/Cas-mediated Genome Editing in the Rat Via Direct Injection of One-Cell Embryos.

Generation of TALEN-mediated FH knockout rat model.

Generation and Characterization of P53 Mutant Mice.

Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer

A Simple and Efficient Method for Generating KO Rats Using In Vitro Fertilized Oocytes

Gene Editing in Rat Embryonic Stem Cells to Produce In Vitro Models and In Vivo Reporters

Generation of Egfp and Cre Knockin Rats by CRISPR/Cas9

Efficient Knockin Mouse Generation by Ssdna Oligonucleotides and Zinc-Finger Nuclease Assisted Homologous Recombination in Zygotes.

Rapid generation and selection of Cas9-engineering TRP53 R172P mice that do not have off-target effects

Characterization of Multidrug Resistance 1a/P-Glycoprotein Knockout Rats Generated by Zinc Finger Nucleases

Generation of Obese Rat Model by Transcription Activator-Like Effector Nucleases Targeting the Leptin Receptor Gene

Improved Rat Genome Gene Prediction by Integration of ESTs with RNA-Seq Information

Characterization of Novel Cytochrome P450 2e1 Knockout Rat Model Generated by Crispr/Cas9

Optimizing Embryo Collection for Application of CRISPR/Cas9 System and Generation of Fukutin Knockout Rat Using This Method